Literature DB >> 27235614

Pharmacologic Therapies in Women's Health: Contraception and Menopause Treatment.

Caitlin Allen1, Ginger Evans2, Eliza L Sutton3.   

Abstract

Female hormones play a significant role in the etiology and treatment of many women's health conditions. This article focuses on the common uses of hormonal therapy. When prescribing estrogen-containing regimens throughout the span of a woman's life, the risks are similar (ie, cardiovascular risk and venous thromboembolism), but the degree of risk varies significantly depending on a woman's particular set of risk factors and the details of the hormone regimen. In addition to estrogens and progestogens, this article also touches on the use of selective steroid receptor modulators in emergency contraception and in treatment of menopause symptoms.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Combined hormonal contraception; Emergency contraception; Estrogen therapy; Genitourinary syndrome of menopause; Long-acting reversible contraception; Menopause transition

Mesh:

Substances:

Year:  2016        PMID: 27235614     DOI: 10.1016/j.mcna.2016.03.008

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  3 in total

1.  Simultaneous quantitation of multiple contraceptive hormones in human serum by LC-MS/MS.

Authors:  Steven W Blue; Andrea J Winchell; Amy V Kaucher; Rachel A Lieberman; Christopher T Gilles; Maria N Pyra; Renee Heffron; Xuanlin Hou; Robert W Coombs; Kavita Nanda; Nicole L Davis; Athena P Kourtis; Joshua T Herbeck; Jared M Baeten; Jairam R Lingappa; David W Erikson
Journal:  Contraception       Date:  2018-01-31       Impact factor: 3.375

2.  The effect and safety of postmenopausal hormone therapy and selective estrogen receptor modulators on kidney outcomes in women: a protocol for systematic review and meta-analysis.

Authors:  Sandra M Dumanski; Sharanya Ramesh; Matthew T James; Amy Metcalfe; Kara Nerenberg; Ellen W Seely; Helen Lee Robertson; Sofia B Ahmed
Journal:  Syst Rev       Date:  2017-07-07

3.  Medroxyprogesterone acetate inhibits wound closure of human endometrial epithelial cells and stromal fibroblasts in vitro.

Authors:  Mickey V Patel; Marta Rodriguez-Garcia; Zheng Shen; Charles R Wira
Journal:  Sci Rep       Date:  2021-12-01       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.